Government investigation finds flaws in the FDA’s orphan drug program

The Food and Drug Administration has failed to ensure that drugs given prized rare-disease status meet the intent of a 35-year-old law, federal officials revealed in a report last week.

Article Source: Government investigation finds flaws in the FDA’s orphan drug program.